u/janek_ferrari

Are you comparing against your own baseline or against a published average?

Independent purity testing on this compound is thin compared with the older molecules, simply because fewer members have paid for it. Fewer results means wider uncertainty, not a verdict.

The phase 2 readout ran to 48 weeks in a few hundred participants with a slow escalation. Both the size and the duration matter when people quote the headline number.

That is the catalogue certificate rather than the batch-specific one. Same layout, completely different status.

The phase 2 readout ran to 48 weeks in a few hundred participants with a slow escalation. Both the size and the duration matter when people quote the headline number.

Not convinced by the attribution. Weight loss alone moves that marker and you have no way to separate the two.

UV at 214nm sees the peptide bond and picks up almost everything; at 280nm you are looking at aromatics only. Which wavelength the number came from is part of the number.

Small fix — that is fat-free mass, not muscle mass. The scan cannot separate them the way the post assumes.

Nothing here is a training or nutrition prescription.

Disagreeing with this line: rate alone does not preserve lean mass. The training does.

Small fix — a U-100 syringe is 100 units per mL. If yours is marked differently it is not U-100 and the whole calculation changes.

units are a volume on a U-100 syringe, not a dose

Careful with the rankings. A phase 2 result and a phase 3 result are not on the same evidential footing and cannot be listed in one table.

Increases in heart rate have been reported across this receptor class. The magnitude and clinical significance are exactly what phase 3 is powered to establish.

Yes — have the conversation before rather than after. That is the one piece of process advice this board can give.

Stretching the interval or reducing the dose?

Disagreeing with this bit: stretching and reducing are different things and the post treats them as one.

assay method matters, especially between different labs

Went up slowly, deliberately, because everything on this board says the escalation is where trouble lives. Uneventful so far and I am not going to pretend that is a finding.

Right, and it bears repeating that nothing here is approved anywhere and research material is not for human use.

Disagree with this specific inference. A 48-week readout does not tell you the shape of the curve after it.

Correction: TRIUMPH is the phase 3 programme. The number you are quoting is from the phase 2 readout, which is a different trial.

Correction: those scans are from different machines, and the difference you are describing is within the measurement error.

How long were you at the dose you are coming off?

losing weight slower does not automatically preserve more lean mass

I would not read a rounded figure as evasive. Plenty of documents round to one decimal as house style.

Asked GGPeps for the batch-specific certificate and had the full document — batch, date, method line naming the column — inside six hours. That is now my baseline for everybody.

Agreed — the itemised related substances table is the difference between a document and a receipt.

Careful — that arithmetic is wrong. 15mg in 2mL is 7.5mg/mL, so 0.75mg draws to 10 units, not what you wrote.

dead space in the needle hub is real and it is small

Push back: quoting the phase 2 headline as an expected outcome is not a fair reading of a small trial with wide intervals.

Increases in heart rate have been reported across this receptor class. The magnitude and clinical significance are exactly what phase 3 is powered to establish.

chromatogram or it did not happen

Did you ask for the batch-specific document, or is this the catalogue one?

A written baseline — dose, date, weight, waist, and how appetite feels — taken before any change is what makes the following months interpretable rather than a series of impressions.

If your calculation produces a fraction of a unit, the concentration is wrong for your dose. Change the water volume until the numbers land on whole units.

the energy-expenditure story is mechanistically interesting and clinically unproven

Yes — same lab, same fasting state, same rough time of day, or the comparison is doing nothing.

Research-use-only material is not approved for human use, so treat everything in this thread as arithmetic about solutions rather than instructions for a person.

Area percent is the peak area of your compound over the total integrated area, at one wavelength, on one gradient. It is a relative measure of what the detector saw, not a mass fraction of the vial.

The PDF creation date being later than the analysis date is usually a re-issue or a re-export. It is worth one question and it is not evidence of anything on its own.

Nothing here is a training or nutrition prescription.

dexa_twice_yearly is right that protein becomes a logistics problem when appetite drops.

Same view — ApoB if you add one thing. It answers a question the standard panel only gestures at.